Clarity Pharmaceuticals (ASX:CU6) Enhances Breast Cancer Pipeline with Cu-SAR-trastuzumab
Clarity Pharmaceuticals (ASX:CU6) enhances its breast cancer pipeline with new radiopharmaceutical and secures critical supply agreement.
The Hub of Australian Finance News
Clarity Pharmaceuticals (ASX:CU6) enhances its breast cancer pipeline with new radiopharmaceutical and secures critical supply agreement.
Elixir Energy Limited (ASX:EXR) suspends its securities from quotation pending an expansion announcement of its Taroom Trough position.
Kinetiko Energy (ASX:KKO) reports successful gas production tests, maintaining a 100% gas encounter rate and initiating an optimization study.
EV Resources (ASX:EVR) advances its Parag project to supply molybdenum to the USA amidst China’s export controls.
Connected Minerals Ltd (ASX:CML) confirms significant drill targets at Swakopmund Uranium Project, planning drilling commencement in Q2 2025.
Matsa Resources Limited (ASX:MAT) reports a new high-grade gold intercept at Fortitude North, enhancing their exploration model and future drilling plans.
VGI Partners Global Investments Limited (ASX:VG1) increases its target dividend to at least 6c per share semi-annually, enhancing yield for investors.
VGI Partners Global Investments Limited (ASX:VG1) reports a $43.1 million loss for the half-year and announces dividends for 2024 and 2025.
Stellar Resources (ASX:SRZ) announces high-grade tin intersections at Queen Hill, advancing the Heemskirk Tin Project.
National Australia Bank extends loan maturity and defers interest payments for Cann Group (ASX:CAN), enhancing financial flexibility.